recent observations regarding the ability of intracellular erythrocyte ( rbc ) antioxidants to decrease o2 metabolite-mediated injury to lung tissues has prompted interest in the rbc antioxidants of patients with lung disease .
C0273115
injury
C0024115
lung disease